Clinical Evaluation of Bedside Pulse Lavage Irrigation Device
Bedside Pulse Lavage Irrigation Project
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
This study evaluates how subjects with intact skin tolerate a water jet (psi 10-12) and how well the water stream is contained by a new containment device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2011
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 13, 2011
CompletedFirst Posted
Study publicly available on registry
October 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedDecember 7, 2022
December 1, 2022
1 year
October 13, 2011
December 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Leak
After each lavage treatment, leak will be assessed by the presence of moisture outside of the lavage chamber. The time period of evaluation will take place immediately after the lavage. The subject will not be followed after their visit is complete.
up to 1 day
Secondary Outcomes (1)
Seals
up to 1 day
Study Arms (1)
Lavage group
EXPERIMENTALHealthy subjects with intact skin will be lavaged within the device in 3 locations on their bodies.
Interventions
Healthy subjects with intact skin will be lavaged through the device for 1 minute on 3 different sites. The stryker pulsavac plus will be used for the lavage.
Eligibility Criteria
You may qualify if:
- Subjects must be healthy and willing to complete the study procedures.
You may not qualify if:
- Subjects must not have any chronic pain conditions or take any pain medications on a regular basis. Must not have any chronic wounds. Must not have any medical conditions that interfere with pain sensation. Must not have an allergy to skin adhesives. Patients must not be taking any immunosuppressive medications. Patients must not have any chronic infections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Baxter Healthcare Corporationcollaborator
Study Sites (1)
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Robert D Galiano, MD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Surgery
Study Record Dates
First Submitted
October 13, 2011
First Posted
October 21, 2011
Study Start
October 1, 2011
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
December 7, 2022
Record last verified: 2022-12